Financial News
Latest News about NTLA
Recent news which mentions NTLA
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2021
October 05, 2021
From Benzinga
3 Most Overvalued Biotech Stocks on the Market Right Now
October 01, 2021
From Motley Fool
Why Shares of Editas Medicine Are Lower This Morning
September 29, 2021
From Motley Fool
Breaking Down CRISPR Technology
September 28, 2021
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 24, 2021
September 24, 2021
From Benzinga
Why Cathie Wood Is Buying 2 Gene-Editing Stocks but Selling Another
September 23, 2021
From Motley Fool
3 Moonshot Stocks Hidden in Cathie Wood’s Portfolios
September 22, 2021
From InvestorPlace
Intellia To Test CRISPR-Engineered TCR-T Cell Candidate In Acute Myeloid Leukemia Patients
September 16, 2021
Tickers
NTLA
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 16, 2021
From Benzinga
7 Gene Editing Stocks Promising to Change our DNA
September 15, 2021
From InvestorPlace
3 Red-Hot Healthcare Stocks to Buy in September
September 09, 2021
From Motley Fool
3 Hot Stocks to Buy in September
September 07, 2021
From Motley Fool
Forget About the Genomic Revolution, the Proteomic Revolution Is Coming
September 03, 2021
From InvestorPlace
Forget About the Genomic Revolution, the Proteomic Revolution Is Coming
September 03, 2021
From InvestorPlace
From InvestorPlace
Will Moderna Buy Editas Medicine to Jump Into Gene Editing?
August 12, 2021
From Motley Fool
Tickers
NTLA
From Motley Fool
10 Biggest Price Target Changes For Friday
August 06, 2021
From Benzinga
99 Biggest Movers From Yesterday
August 06, 2021
From Benzinga
From InvestorPlace
Why Intellia Therapeutics Shares Are Trading Higher Today
August 05, 2021
Tickers
NTLA
From Benzinga
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
August 04, 2021
From Benzinga
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
August 01, 2021
From Benzinga
3 Things About Illumina That Smart Investors Know
July 30, 2021
From Motley Fool
3 Things About Regeneron That Smart Investors Know
July 29, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
